China Shineway Pharmaceutical Group Limited logo

China Shineway Pharmaceutical Group Limited

2877.HK

HKSEHealthcareDrug Manufacturers - Specialty & Generic

最新数据

HK$7.97

−HK$0.07 · -0.87%

8月24日 15:55 HKT

2877.HK公司概览

盘中时间采用HKT。市场数据可能有所延迟。

公司概况

公司网站

As an investment holding enterprise, China Shineway Pharmaceutical Group Limited is dedicated to the development, production, and sale of traditional Chinese medicines throughout the People's Republic of China and Hong Kong. Its extensive product range includes modern Chinese pharmaceuticals delivered as soft capsules, granular preparations, and injectable forms, alongside specialized Traditional Chinese Medicine (TCM) Formula Granules. These offerings cater to a broad spectrum of therapeutic needs, such as cardiovascular and cerebrovascular health, anti-viral applications, orthopedic conditions, pediatric ailments, gynecological care, and gastrointestinal issues. Furthermore, the company is involved in the trading of agricultural commodities. Founded in 2004, its headquarters are situated in Shijiazhuang, PRC, and it functions as a subsidiary of Forway Investment Limited.

行业
Drug Manufacturers - Specialty & Generic
部门
Healthcare
总部
CN
首席执行官
Zhenjiang Li
上市以来
2004年12月2日
雇员
2,822

市场位置

成交量
60.1万
0.72× 平均值
平均成交量
83.77万
日均成交量
市值
60.36亿 HKD
贝塔
0.72
市场参考 1

财务数据

财务快照

最近十二个月

估值与收益率

企业价值
-10.22亿 CNY
市盈率(TTM)
5.48×
市净率(TTM)
0.64×
市销率(TTM)
1.65×
EV/EBITDA
-1.38×
盈利收益率
16.28%
自由现金流收益率
16.69%
股息率
7.60%

盈利能力和效率

毛利率
72.28%
营业利润率
21.75%
净利润率
30.30%
净资产收益率
11.78%
资产收益率
8.81%
投入资本回报率
5.93%

财务健康

负债权益比
0.04×
流动比率
3.71×

2877.HK同业公司

持有2877.HK的ETF

报告持有此股票敞口的交易所交易基金。

继续GoAI的研究

在 GoAI 中研究2877.HK

research.disclaimer